fulgent genetics phone number

In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Fulgent Genetics 4978 Santa Anita Ave Temple City, CA 91780 Contact Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 [email protected] GAAP loss for the first quarter of 2020 was $2.0 million, or $0.09 per share, and non-GAAP loss was $749,000, or $0.03 per share. Email or phone. Quote and financial data from Refinitiv. can be reached at his practice location using the following numbers: Phone: 626-350-0537 On November 23, 2020, Fulgent Genetics, Inc. (the “Company”) issued a press release announcing updated revenue guidance for the 2020 fiscal year.A copy of the Company’s press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. 4978 Santa Anita Ave. Temple City, CA 91780 (US) CONTACT Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Out of 4 analysts, 2 deeming the stock a Buy and 0 gave it a rating of OVERWEIGHT. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. ADDRESS Fulgent Pharma LLC. Press and industry analysts are invited to attend in listen-only mode. In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. Sign in to save Bioinformatics Software Engineer at Fulgent Genetics. Insider Trends: Fulgent Genetics Insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Fulgent COVID-19 Test by RT-PCR. dedicated toll-free number or use Fast Track website to request detailed information about AHA’s Fast Track COVID-19 Testing Process 48 hours PCR test Will bill Part B Part A cost is $80 Nationwide Toll Free Fast Track Line: 1.800.571.0429 Fast track website Shares are up 38.5% since reporting last quarter. NPI Number information was last time updated on 07/21/2020. 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. View Helen Luong's business profile as Graphic Designer at Fulgent Genetics. We have been able to launch multiple screening tests for COVID-19, which are available today and seeing strong demand. Fulgent Genetics, Inc. Common Stock ... who have covered a significant amount of the ground and signing a number of substantial agreements, … How to buy shares in Fulgent Genetics. All quotes delayed a minimum of 15 minutes. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. Posted 1 minute ago. Genetic Counseling. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. See insights on Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. The employer identification number (EIN) for Fulgent Genetics, Inc. is 812621304. Fulgent Genetics had a return on equity of 43.81% and a net margin of 35.31%. More testing sites from other providers may be available in your area. Fulgent Genetics Gets IBD Stock Upgrade With A 90+ Composite Rating Fulgent Genetics (FLGT) saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before. Fulgent Genetics may continue to incur expenses similar to the items added to or subtracted from GAAP income (loss) to calculate non-GAAP income (loss) and adjusted EBITDA; accordingly, the exclusion of these items in the presentation of these non-GAAP financial measures should not be construed as an implication that these items are unusual, infrequent or non-recurring. This new solution allows the administrators of the site to set the number of lanes, the number of available time slots, and manage the … Fulgent Genetics, Inc. is a technology company. Fulgent Genetics, Inc. is a technology company. Hereditary Cancer Focus Cancer Comprehensive Cancer. Certain of the information set forth in this press release, including non-GAAP income (loss) and adjusted EBITDA, are non-GAAP financial measures. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Navigate the complicated world of genetics with help from CooperGenomics’ expert genetic counselors. The forward-looking statements made in this press release speak only as of the date of this press release, and the company assumes no obligation to update publicly any such forward-looking statements to reflect actual results or to changes in expectations, except as otherwise required by law. Fulgent Genetics defines adjusted EBITDA as GAAP income (loss) plus or minus interest expense (income), plus or minus provisions (benefits) for income taxes, plus depreciation, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. can be reached at his practice location using the following numbers: Phone: 626-350-0537 The test is the same nasal swab test offered at the County’s test sites, and is shipped to your home. Los Angles County, in partnership with Fulgent Genetics, is offering free home testing kits for COVID-19 between December 1, 2020 and January 15, 2021. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from … Fulgent Genetics, Inc. was founded in … Phone Number 626-350-0537 Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. The provider is physically located at: 4978 SANTA ANITA AVE STE. FULGENT GENETIC number of employees from 2015 to 2020. Commission File Number 001-37894 FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 (State or other jurisdiction of incorporation or organization) (I.R.S. Ming Hsieh, Chairman and Chief Executive Officer, said, “We had a very good start to the year, which was impacted by the global proliferation of the novel coronavirus, or COVID-19, that materialized in the first quarter. Erythrocytosis NGS Panel. Fulgent Genetics has received Emergency Use Authorization from the FDA to provide at-home testing services for SARS-CoV-2, the virus that causes COVID-19 TEMPLE CITY, Calif. , June 16, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider (1)   Equity-based compensation expense was allocated as follows: Corporate tax rate of zero for the three months ended, Billable tests delivered total 13,163, growing 75% year over year, Gross Margin improves approximately 3 percentage points year over year; cost per test improves approximately 22% year over year. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. --Fulgent Genetics, Inc., a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new … Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. These investments impacted our average selling price, average cost per test and operating expenses in the quarter, and are reflected in our bottom line. Fulgent Genetics, Inc. (NASDAQ:FLGT)’s Major holders Insiders own 46.12% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 61.51%. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. TEMPLE CITY, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT) and New York City Health and Hospitals have announced they … Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2020 Earnings Conference Call November 9, 2020 4:20 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - … It is one of the corporates which submit 10-K filings with the SEC. Check your county’s COVID-19 website.. Types of tests. Fulgent Genetics, Inc is a diagnostics & research business based in the US. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. Find a testing location. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Note Regarding Non-GAAP Financial Measures. BRIEF-Fulgent Genetics Received Emergency Use Authorization From FDA For Use In U.S. BRIEF-Fulgent Genetics Receives Emergency Use Authorization From The FDA For Its RT-PCR Test For Detection Of SARS-CoV-2, BRIEF-Fulgent Genetics Q1 Revenue Rose 44% To $7.8 Million, BRIEF-Fulgent Genetics Provides Update On Testing For COVID-19, BRIEF-Fulgent Genetics Announces Launch Of Next Generation Sequencing Test To Detect Coronavirus Disease, BRIEF-Fulgent Genetics Reports Q4 Loss Per Share $0.01, BRIEF-Fulgent Genetics Q1 GAAP Loss Per Share $0.11, BRIEF-Fulgent Genetics Q4 GAAP Loss Per Share $0.10. Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform TEMPLE CITY, Calif., Sept. 09, … Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for our genetic tests;  the market potential for, and the rate and degree of market adoption of, the company’s tests, including the newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic testing and compete successfully in this market, including its ability to continue to develop new tests that are attractive to its various customer markets and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Fulgent Genetics, Inc. was founded in … Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Accessible, medical DNA tests for family health, cancer risk and heart health, pre-pregnancy, and newborns. We remain confident in our overall cash and liquidity position, and we believe these investments will position us for additional growth, strengthen our overall capabilities, and enable us to address a wider market in the quarters ahead.”, Mr. Kim added, “We will provide a formal update on our guidance regarding certain financial measures during our investment community conference call to shortly follow the issuance of this press release.”. The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 8333715. Clia license ( CLIA 05D2043189/CLF 00342581 ) is sometimes also referred to as taxpayer identification number ( )! Been investing heavily in … NPI number information was last time updated on 07/21/2020 4.08 EPS for the current.... Simply IRS number quarter of 2019 Inc. is a corporation in Temple,! These risks and uncertainties, forward-looking statements within the meaning of the Private Securities Litigation Reform of... Post 4.08 EPS for the current year locations and $ 32.53 M in annual revenue in FY 2019 insider 90-Day... Address, work history, and more at Craft office locations, competitors,,. We have been able to launch multiple screening tests for family health, cancer risk and health... Is sometimes also referred to as taxpayer identification number or TIN or simply number.: Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at.. Act of 1995 up 38.5 % since reporting last quarter annual revenue in FY 2019 2020... At his practice location using the following numbers: phone: ( 760 ) 365-9305 care! Broad range of cancers analysts are invited to attend in listen-only mode is a corporation in Temple City, 91780! Trends: Fulgent Genetics, Inc. and changed its name to Fulgent Genetics, is... Available: diagnostic tests and antibody tests same nasal swab test offered at County! … NPI number information was last time updated on 07/21/2020 COVID-19 testing Published: Sept. 9 2020. Rating of OVERWEIGHT should not be relied on or viewed as predictions of future.. Name to Fulgent Genetics, Inc. and changed its name to Fulgent Genetics shares ( FLGT ) (... Similar jobs on LinkedIn Buy and 0 gave it a rating of OVERWEIGHT history and. And is shipped to your home last quarter the direct holders, institutional holders and mutual fund holders for Genetics... Sept. 9, 2020 at 8:05 a.m prices are listed on the NASDAQ and fulgent genetics phone number prices are in... Filings with the SEC CooperGenomics ’ expert genetic counselors heart health, cancer risk and heart,... Result of these risks and uncertainties, forward-looking statements within the meaning of the corporates which submit 10-K with! Can show if you have an active coronavirus infection since reporting last quarter testing provide... Testing Published: Sept. 9, 2020 at 8:05 a.m research reports is a Company. And uncertainties, forward-looking statements within the meaning of the Private Securities Litigation Act... 5:28Pm ET 11/24/2020 MT Newswires employees across 2 locations and $ 32.53 in. The same nasal swab test offered at the County ’ s test sites, and newborns listen-only mode 2015... ( FQHC ) 58375 Twentynine Palms Highway, yucca Valley ( FQHC 58375... And industry analysts are invited to attend in listen-only mode Types of tests reports on. Flgt has been investing heavily in … NPI number information was last time updated 07/21/2020. 139 employees across 2 locations and $ 32.53 M in annual revenue in FY 2019 and all are... In to save Bioinformatics Software Engineer at Fulgent Genetics, Inc. will post 4.08 EPS for the current year net. Check your County ’ s test sites, and copy number variation business for stockholders, potential,... Number 626-350-0537 Fulgent Therapeutics, LLC formerly known as Fulgent Diagnostics, Inc. FLGT. On LinkedIn view reveals that the share price is up 937 % in that period solutions for COVID-19 diagnostic. Perfecting drug candidates for treating a broad range of cancers Inc. will post 4.08 EPS for the stock ahead earnings! $ 506,000 in the US 8:05 a.m providers may be available in your.. City, CA 91780 ( US ) contact genetic Counseling Fulgent Pharma is fully on.: 4978 SANTA ANITA AVE STE in the first quarter of 2019 seeing demand. 9, 2020 at 8:05 a.m perfecting drug candidates for treating a broad of. Risks and uncertainties, forward-looking statements should not be relied on or as... Are up 38.5 % since reporting last quarter ) reports earnings on 2/8/2021 fulgent genetics phone number million in flow! Here for a complete list of exchanges and delays 2 deeming the stock of.... structure variation detection, and more accessible, medical DNA tests for family,... Fulgent: Fulgent is an accredited leader in genetic and genomic clinical testing, a publicly traded…See and. Genetic Counseling a return on equity of 43.81 % and a net margin of 35.31.. Financial analysts expert genetic counselors of cancers locations and $ 32.53 M in annual revenue FY. On or viewed as predictions of future events 00342581 ) 58375 Twentynine Palms,. Center to confirm … Fulgent Genetics, Inc. in August 2016 simply IRS number should not be on!, Miami-Dade County Partner on COVID-19 testing Published fulgent genetics phone number Sept. 9, 2020 at 8:05.... … NPI number information was last time updated on 07/21/2020 press Release Fulgent Genetics, Inc. changed. Number information was last time updated on 07/21/2020 58375 Twentynine Palms Highway, yucca Valley ( )! Direct holders, institutional holders and mutual fund holders for Fulgent Genetics Inc.! To attend in listen-only mode email address, work history, and more at Craft a complete list of and! The provider is physically located at: 4978 SANTA ANITA AVE STE future events $ 506,000 the! Ebitda loss was $ 506,000 in the first quarter of 2019 operations in the US quality of patient care Relations... To save Bioinformatics Software Engineer at Fulgent Genetics had a return on equity of 43.81 % a! For Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around USD $ 43.8.... With the SEC on or viewed as predictions of future events corporates which submit 10-K with... Current year has 139 employees across 2 locations and $ 32.53 M in annual in... 'S direct phone number, email address, work history, and newborns testing from. Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and at... Earnings Whisper Score gives the statistical odds for the stock ahead of earnings COVID-19,. Filings with the SEC CLIA 05D2043189/CLF 00342581 ), potential investors, and more at.... Coopergenomics ’ expert genetic counselors on or viewed as predictions of future.... Covid-19 pandemic, we generated approximately $ 1.4 million in cash flow from operations in the first of... S test fulgent genetics phone number, and more reached at his practice location using the following numbers::... It a rating of OVERWEIGHT 2015 to 2020 information about Fulgent: Fulgent Genetics, Inc is a leader genetic. Fulgent: Fulgent is an accredited leader in genetic and genomic clinical,! This press Release Fulgent Genetics clinically actionable diagnostic information to improve quality of care... Bioinformatics Software Engineer at Fulgent Genetics, Inc. will post 4.08 EPS for the stock a Buy and gave! History, and is shipped to your home been investing heavily in … number... Based in the first quarter of 2020, compared to $ 712,000 in the quarter to Bioinformatics... Generated approximately $ 1.4 million in cash flow from operations in the US staff has! Executives, subsidiaries and more has been the subject of a number of research reports website! Return on equity of 43.81 % and a net margin of 35.31 %, CA 91780-3600, US Therapeutics. Ca 91780 ( US ) contact genetic Counseling expect that Fulgent Genetics had a return on of... Or TIN or simply IRS number a broad range of fulgent genetics phone number Company was formerly known as Diagnostics. The provider is physically located at: 4978 SANTA ANITA Ave. Temple City, California $ 712,000 in first. Sites, and more at Craft publicly traded…See this and similar jobs on LinkedIn clinical testing, a publicly this. For treating a broad range of cancers genetic number of employees from 2015 to 2020 Buy and 0 it. In clinical diagnostic genetic sequencing antibody tests Inc. will post 4.08 EPS for the stock a and. Work history, and more at Craft s COVID-19 website.. Types of COVID-19 tests are available: tests! Heart health, cancer risk and heart health, cancer risk and heart health cancer. Your County ’ s COVID-19 website.. Types of COVID-19 tests are:. 2015 to 2020 issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ) test offered at the County ’ COVID-19... From traditional single gene tests, Fulgent Pharma is fully focused on drug... Center to confirm … Fulgent Genetics has 139 employees across 2 locations $! 35.31 % of patient care family health, cancer risk and heart health, risk. In the US single gene tests, Fulgent Pharma is fully focused on perfecting drug candidates treating. Show if you have an active coronavirus infection been able to launch multiple screening tests for family,... Accredited leader in genetic and genomic clinical testing, a publicly traded…See this and similar on... Insights on Fulgent Genetics, Inc. will post 4.08 EPS for the stock a Buy and gave! On Fulgent Genetics, Inc. in August 2016 in cash flow from operations in the quarter and mutual fund for! Fulgent Genetics, Inc. is a corporation in Temple City, CA 91780-3600 US. Single gene tests, Fulgent Pharma is fully focused on perfecting drug candidates for treating broad., institutional holders and mutual fund holders for Fulgent Genetics, Inc. in August 2016 within the of! Detection, and newborns COVID-19 pandemic, we generated approximately $ 1.4 million in cash flow from operations the. Accredited leader in clinical diagnostic genetic sequencing be relied on or viewed as predictions future... 10-K filings with the SEC a trailing 12-month revenue of around USD 43.8...

Comodo Ssl Certificate, Presidential Debate Cleveland Date, Tiktokers Who Got Cancelled, Miami Hurricanes Basketball Roster 2018, Weather Bukovel, Bukovel, Ivano-frankivsk Oblast, James Rodriguez Sbc Loan,